Pradžia › Hipertrofinė kardiomiopatija › Masčusetsas
Hipertrofinė kardiomiopatija klinikiniai tyrimai Masčusetsas
6 tyrimai dėl Hipertrofinė kardiomiopatija ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT05489705Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-06-04 · NCT06034405A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Boston
- Imbria Investigational Site, Burlington
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-18 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Boston Children's Hospital, Boston
Renkami dalyviai2 fazė
Amžius 8 ir vyresni · Vyrams · Atnaujinta 2026-05-04 · NCT06092034HCMR Re-Imaging Study
- Brigham & Women's Hospital, Boston
- Tufts Medical Center, Medford
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-03-18 · NCT07054073Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
- Analysis Group Inc., Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-11-07 · NCT06551129Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.